Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$217K Buy
4,959
+92
+2% +$4.4K 0.23% 110
2019
Q4
$244K Buy
4,867
+1
+0% +$47 0.2% 144
2019
Q3
$225K Buy
+4,866
New +$210K 0.19% 147
2019
Q2
Sell
-4,955
Closed -$219K 198
2019
Q1
$219K Buy
+4,955
New +$212K 0.19% 148
2018
Q3
Sell
-5,398
Closed -$216K 205
2018
Q2
$216K Sell
5,398
-32
-0.6% -$1.26K 0.13% 166
2018
Q1
$218K Buy
5,430
+604
+13% +$25.1K 0.12% 188
2017
Q4
$208K Hold
4,826
0.12% 167
2017
Q3
$240K Buy
4,826
+451
+10% +$21.8K 0.14% 134
2017
Q2
$210K Buy
+4,375
New +$209K 0.11% 190

Other funds holding SNY

Miles Capital's SNY Position: Q1 2020 in Review

Miles Capital increased its Sanofi (SNY) stake by 1.9% in Q1 2020, buying an estimated $4.4K and bringing the position to 4,959 shares worth $217K. The position accounts for 0.23% of the portfolio, ranked #110.

Miles Capital first reported a position in SNY in Q2 2017 and has held it in 9 quarters since. The position peaked at $244K in Q4 2019. 547 funds tracked by Wall St. Rank hold SNY as of Q1 2020.

  • Miles Capital held 4,959 shares of Sanofi worth $217K as of Q1 2020.
  • Miles Capital bought 92 Sanofi shares in Q1 2020, an estimated $4.4K.
  • Sanofi made up 0.23% of Miles Capital's portfolio in Q1 2020, its #110 holding.
  • Miles Capital first reported a position in Sanofi in Q2 2017 and has held it in 9 quarters since.
  • Miles Capital's Sanofi position peaked at $244K in Q4 2019.
  • 547 funds tracked by Wall St. Rank held Sanofi as of Q1 2020.

Based on Miles Capital's 13F filing for Q1 2020, filed 13 May 2020.